trending Market Intelligence /marketintelligence/en/news-insights/trending/gkkxxim9xwsmmlmw22plng2 content esgSubNav
In This List

UDG Healthcare adds board member

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


UDG Healthcare adds board member

UDG Healthcare plc added Erik Van Snippenberg to its board as a nonexecutive director.

Snippenberg was most recently with GlaxoSmithKline Plc as senior vice president and area head for Europe and Canada. He was also a member of GlaxoSmithKline's global pharmaceutical management team.

Meanwhile, UDG Healthcare said Chris Corbin, a nonexecutive director of the company due to retire on April 2019, has agreed to extend his term. Corbin will be subject to re-election at the company's annual general meeting.

The Dublin-based company provides clinical, commercial, communication and packaging services to the healthcare industry.